Health Viewpoints

FDA Authorizes ‘Traditional’ Novavax COVID Vaccine, But Critics Question Safety Claims

FDA Authorizes ‘Traditional’ Novavax COVID Vaccine, But Critics Question Safety Claims
Novavax already is available in other countries, including Canada and Australia, under the name Nuvaxovid. Photo by JEROEN JUMELET/ANP/AFP via Getty Images
|Updated:
The U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine for adults 18 and over.
The EUA is for the two-dose primary series targeting the original Wuhan SARS-CoV-2 virus — limiting the vaccine’s use, as about two-thirds of Americans already have completed a primary series of either the Pfizer, Moderna or Johnson & Johnson vaccines.
Julie Comber, The Defender
Julie Comber, The Defender
Author
Julie Comber is a freelance science reporter for The Defender. She is a mother, activist, writer and singer-songwriter. She has a Master's in human genetics, a Master's in bioethics and a Ph.D. in environmental education. Julie seeks to protect children from corporate thieves. She acknowledges, with gratitude, to live on the traditional and unceded territory of the Algonquin Anishinabe.
Related Topics